Exelixis Inc. buy Guggenheim
Start price
22.01.25
/
50%
€32.38
Target price
22.01.26
-
Performance (%)
15.84%
End price
23.01.26
€37.51
Summary
This prediction ended on 23.01.26 with a price of €37.51. The prediction had a final performance of 15.84%. Guggenheim has a follow-up prediction for Exelixis Inc. where he still thinks Exelixis Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -1.239% | -1.239% | 21.394% |
| iShares Core DAX® | -1.764% | 2.259% | 15.847% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 4.686% |
| iShares Nikkei 225® | -2.451% | 4.086% | 16.083% |
| iShares S&P 500 | -2.252% | -0.151% | 1.636% |
Comments by Guggenheim for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten

